Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroendocrine Carcinomas of Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Testing effectiveness (Phase 2)WithdrawnNCT00003514
What this trial is testing

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Who this might be right for
Merkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more
Burzynski Research Institute
Testing effectiveness (Phase 2)Study completedNCT00427349
What this trial is testing

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Eastern Cooperative Oncology Group 46
Testing effectiveness (Phase 2)Study completedNCT01024387
What this trial is testing

AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 60
Testing effectiveness (Phase 2)Study completedNCT05259696
What this trial is testing

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

Who this might be right for
OncologyMelanomaOvarian Cancer+14 more
Palleon Pharmaceuticals, Inc. 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05988918
What this trial is testing

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Who this might be right for
Pancreatic AdenocarcinomaAdenosquamous CarcinomaPancreatic Neuroendocrine Tumor+4 more
University of Michigan Rogel Cancer Center 17
Large-scale testing (Phase 3)Looking for participantsNCT07087054
What this trial is testing

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 141
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Testing effectiveness (Phase 2)Study completedNCT00093782
What this trial is testing

Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma

Who this might be right for
Metastatic Gastrointestinal Carcinoid TumorPulmonary Carcinoid TumorRecurrent Gastrointestinal Carcinoid Tumor+1 more
National Cancer Institute (NCI) 36
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Not applicableLooking for participantsNCT05297734
What this trial is testing

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Who this might be right for
End of LifeCancer
Stanford University 2,996
Testing effectiveness (Phase 2)Study completedNCT00781911
What this trial is testing

Cixutumumab (IMC-A12) in Islet Cell Cancer

Who this might be right for
CarcinomaNeuroendocrine Tumors
Eli Lilly and Company 43
Early research (Phase 1)Ended earlyNCT05432193
What this trial is testing

FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerEsophageal Cancer+4 more
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company 20
Testing effectiveness (Phase 2)Ended earlyNCT01065805
What this trial is testing

Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Who this might be right for
Brain CancerCancerSolid Tumor+1 more
AHS Cancer Control Alberta 94
Not applicableStudy completedNCT06570174
What this trial is testing

Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients

Who this might be right for
Pancreatic CancerCholangiocarcinomaIntraductal Papillary Mucinous Neoplasm+2 more
Yonsei University 60
Testing effectiveness (Phase 2)Study completedNCT02132468
What this trial is testing

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

Who this might be right for
Neuroendocrine Tumors
Mateon Therapeutics 18
Early research (Phase 1)Study completedNCT02639026
What this trial is testing

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Who this might be right for
MetastaticMelanomaNon Small Cell Lung Cancer (NSCLC)+2 more
Abramson Cancer Center at Penn Medicine 53
Testing effectiveness (Phase 2)Study completedNCT04505553
What this trial is testing

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

Who this might be right for
Appendix CarcinomaColon CarcinomaEsophageal Carcinoma+10 more
University of Washington 78
Testing effectiveness (Phase 2)Ended earlyNCT01215578
What this trial is testing

Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more
Assistance Publique - Hôpitaux de Paris 33
Next Page